412 related articles for article (PubMed ID: 32064560)
1. Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Koda W; Inoue D; Ogi T; Yoshida K; Gabata T
Eur Radiol; 2020 Jun; 30(6):3438-3447. PubMed ID: 32064560
[TBL] [Abstract][Full Text] [Related]
2. Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background.
Yoneda N; Matsui O; Kitao A; Kozaka K; Kobayashi S; Sasaki M; Yoshida K; Inoue D; Minami T; Gabata T
Radiographics; 2016; 36(7):2010-2027. PubMed ID: 27740898
[TBL] [Abstract][Full Text] [Related]
3. OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma.
Ueno A; Masugi Y; Yamazaki K; Komuta M; Effendi K; Tanami Y; Tsujikawa H; Tanimoto A; Okuda S; Itano O; Kitagawa Y; Kuribayashi S; Sakamoto M
J Hepatol; 2014 Nov; 61(5):1080-7. PubMed ID: 24946283
[TBL] [Abstract][Full Text] [Related]
4. Peri-tumoral hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced MRI in hepatocellular carcinomas: correlation with peri-tumoral hyperplasia and its pathological features.
Yoneda N; Matsui O; Kitao A; Komori T; Kozaka K; Ikeda H; Yoshida K; Inoue D; Minami T; Koda W; Kobayashi S; Gabata T
Abdom Radiol (NY); 2018 Aug; 43(8):2103-2112. PubMed ID: 29260280
[TBL] [Abstract][Full Text] [Related]
5. Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature.
Yoneda N; Matsui O; Kitao A; Kita R; Kozaka K; Koda W; Kobayashi S; Gabata T; Ikeda H; Nakanuma Y
Jpn J Radiol; 2013 Jul; 31(7):480-90. PubMed ID: 23771695
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.
Tsuboyama T; Onishi H; Kim T; Akita H; Hori M; Tatsumi M; Nakamoto A; Nagano H; Matsuura N; Wakasa K; Tomoda K
Radiology; 2010 Jun; 255(3):824-33. PubMed ID: 20501720
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.
Kitao A; Zen Y; Matsui O; Gabata T; Kobayashi S; Koda W; Kozaka K; Yoneda N; Yamashita T; Kaneko S; Nakanuma Y
Radiology; 2010 Sep; 256(3):817-26. PubMed ID: 20663969
[TBL] [Abstract][Full Text] [Related]
8. Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.
Kim YY; Park MS; Aljoqiman KS; Choi JY; Kim MJ
Clin Mol Hepatol; 2019 Sep; 25(3):223-233. PubMed ID: 30661336
[TBL] [Abstract][Full Text] [Related]
9. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
10. Uptake of gadoxetic acid in hepatobiliary phase magnetic resonance imaging and transporter expression in hypovascular hepatocellular nodules.
Morisaka H; Motosugi U; Ichikawa S; Ichikawa T; Kondo T; Onishi H
Eur J Radiol; 2021 May; 138():109669. PubMed ID: 33770738
[TBL] [Abstract][Full Text] [Related]
11. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
12. Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Yamashita T; Kitao A; Matsui O; Hayashi T; Nio K; Kondo M; Ohno N; Miyati T; Okada H; Yamashita T; Mizukoshi E; Honda M; Nakanuma Y; Takamura H; Ohta T; Nakamoto Y; Yamamoto M; Takayama T; Arii S; Wang X; Kaneko S
Hepatology; 2014 Nov; 60(5):1674-85. PubMed ID: 24700365
[TBL] [Abstract][Full Text] [Related]
13. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging.
Kitao A; Matsui O; Yoneda N; Kozaka K; Shinmura R; Koda W; Kobayashi S; Gabata T; Zen Y; Yamashita T; Kaneko S; Nakanuma Y
Eur Radiol; 2011 Oct; 21(10):2056-66. PubMed ID: 21626360
[TBL] [Abstract][Full Text] [Related]
14. Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Koda W; Gabata T; Yamashita T; Kaneko S; Nakanuma Y; Kita R; Arii S
Radiology; 2012 Dec; 265(3):780-9. PubMed ID: 23175543
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of β-catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Koda W; Minami T; Inoue D; Yoshida K; Yamashita T; Yamashita T; Kaneko S; Takamura H; Ohta T; Ikeda H; Sato Y; Nakanuma Y; Harada K; Kita R; Gabata T
Hepatol Res; 2018 Feb; 48(2):205-216. PubMed ID: 28488786
[TBL] [Abstract][Full Text] [Related]
16. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
17. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.
Narita M; Hatano E; Arizono S; Miyagawa-Hayashino A; Isoda H; Kitamura K; Taura K; Yasuchika K; Nitta T; Ikai I; Uemoto S
J Gastroenterol; 2009; 44(7):793-8. PubMed ID: 19404564
[TBL] [Abstract][Full Text] [Related]
18. Significance of the Signal Intensity of Gadoxetic Acid-enhanced MR Imaging for Predicting the Efficacy of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma.
Fujita N; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Morita K; Shirabe K; Koto K; Kubo Y; Oda Y; Honda H
Magn Reson Med Sci; 2016; 15(1):111-20. PubMed ID: 26346403
[TBL] [Abstract][Full Text] [Related]
19. Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
Kitao A; Matsui O; Zhang Y; Ogi T; Nakada S; Sato Y; Harada K; Yoneda N; Kozaka K; Inoue D; Yoshida K; Koda W; Yamashita T; Yamashita T; Kaneko S; Kobayashi S; Gabata T
Radiology; 2023 Feb; 306(2):e220531. PubMed ID: 36219111
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
